CAS: 603288-22-8 - LY2090314
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY2090314 REF: AN-AG00ECDZCAS: 603288-22-8 | 99% | 90.00 €~469.00 € | Thu 02 May 24 |
 | LY2090314 REF: TM-T1755CAS: 603288-22-8 | 99.88% | 48.00 €~624.00 € | Thu 09 May 24 |
 | LY 2090314 REF: TR-L395020CAS: 603288-22-8 | - - - | 32,173.00 € | Wed 12 Jun 24 |
 | LY 2090314 REF: 3D-FL104294CAS: 603288-22-8 | Min. 95% | To inquire | Thu 13 Jun 24 |
Ref: AN-AG00ECDZ
| 5mg | 90.00 € | |
| 10mg | 123.00 € | |
| 25mg | 175.00 € | |
| 50mg | 294.00 € | |
| 100mg | 469.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
LY2090314
CAS:603288-22-8
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based …
Formula:
C28H25FN6O3
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
512.53
- Inhibitors
- Stem Cell and Derivatives
- Stem Cells
- PI3K/Akt/mTOR Signaling
- See more categories
- gsk-3
Ref: TM-T1755
| 1mg | 48.00 € | |
| 2mg | 62.00 € | |
| 5mg | 94.00 € | |
| 10mg | 149.00 € | |
| 25mg | 260.00 € | |
| 50mg | 423.00 € | |
| 100mg | 624.00 € | |
| 1ml*10 (DMSO) | 106.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: TR-L395020
| 25mg | 32,173.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
LY 2090314
CAS:603288-22-8
Inhibitor of GSK3 kinase
Formula:
C28H25FN6O3
Purity:
Min. 95%
Molecular weight:
512.54 g/mol
Ref: 3D-FL104294
| 10mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
